Form of Javelin Stockholder Voting Agreement



 Exhibit 10.2 
 FORM OF VOTING AGREEMENT 
 FOR HOLDERS OF COMPANY
COMMON STOCK 
 THIS VOTING AGREEMENT (“Agreement”), dated as of December 18, 2009, is made by and
among Myriad Pharmaceuticals, Inc., a Delaware corporation (“Parent”), Javelin Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the undersigned holder (“Stockholder”) of shares of
capital stock of the Company (the “Shares”). 
 WHEREAS, Parent, MPI Merger Sub, Inc., a Delaware corporation
and a wholly owned subsidiary of Parent (“Merger Sub”), and the Company have entered into an Agreement and Plan of Merger, dated of even date herewith (as such agreement may be subsequently amended or modified, the “Merger
Agreement”), providing for the merger of Merger Sub with and into the Company (the “Merger”); 
 WHEREAS, Stockholder beneficially owns and has sole voting power (or shares such power with Stockholder’s spouse) with respect to the number of Shares, and holds stock options or other rights to acquire the number of Shares, indicated
opposite Stockholder’s name on Schedule 1 attached hereto; 
 WHEREAS, as an inducement to, and a condition to the
willingness of, Parent and Merger Sub to enter into the Merger Agreement, and in consideration of the substantial expenses incurred and to be incurred by them in connection therewith, Stockholder has agreed to enter into and perform this Agreement;
and 
 WHEREAS, all capitalized terms used in this Agreement without definition herein shall have the meanings ascribed to them
in the Merger Agreement. 
 NOW, THEREFORE, in consideration of, and as a condition to, Parent and Merger Sub entering into the
Merger Agreement and proceeding with the transactions contemplated thereby, and in consideration of the expenses incurred and to be incurred by them in connection therewith, Stockholder, Parent and the Company agree as follows: 
 1. Agreement to Vote Shares. Stockholder agrees that, prior to the Expiration Date (as defined in Section 2 below), at any
meeting of the stockholders of the Company or any adjournment or postponement thereof, or in connection with any written consent of the stockholders of the Company, with respect to the Merger, the Merger Agreement or any Company Acquisition
Proposal, Stockholder shall: 
 (a) appear at such meeting or otherwise cause the Shares and any New Shares (as defined in
Section 3 below) to be counted as present thereat for purposes of calculating a quorum; 
 (b) from and after the date
hereof until the Expiration Date, vote (or cause to be voted) or deliver a written consent (or cause a written consent to be delivered) covering all of the Shares and any New Shares that Stockholder shall be entitled to so vote: (i) in favor of
adoption and approval of the Merger Agreement and all other transactions contemplated by the Merger Agreement and any matter necessary for consummation of the Merger as to which stockholders of the Company are called upon to vote in favor of or
consent to and (ii) against any Company Acquisition Proposal. Stockholder shall not take or commit or agree to take any action inconsistent with the foregoing. 







 2. Expiration Date. As used in this Agreement, the term “Expiration
Date” shall mean the earlier to occur of (a) the Merger Effective Time, (b) such date and time as the Merger Agreement shall be terminated pursuant to Article X thereof or otherwise, or (c) upon mutual written agreement of
each of the parties to terminate this Agreement. This Agreement shall automatically terminate upon the Expiration Date. Upon termination or expiration of this Agreement, no party shall have any further obligations or liabilities under this
Agreement; provided, however, such termination or expiration shall not relieve any party from liability for any willful breach of this Agreement or acts of bad faith prior to termination hereof. 
 3. Additional Purchases. Stockholder agrees that any shares of capital stock or other equity securities of the Company that
Stockholder purchases or with respect to which Stockholder otherwise acquires sole voting power (or shared voting power with Stockholder’s spouse) after the execution of this Agreement and prior to the record date for determining the Company
stockholders entitled to vote with respect to the Merger, whether by the exercise of any stock options or otherwise (“New Shares”), shall be subject to the terms and conditions of this Agreement to the same extent as if they
constituted the Shares. 
 4. Agreement to Retain Shares. From and after the date hereof until the Expiration Date,
Stockholder shall not, directly or indirectly, knowingly take any action that would make any representation or warranty of Stockholder contained herein untrue or incorrect in any material respect or have the effect of preventing or disabling
Stockholder from performing Stockholder’s obligations under this Agreement. Notwithstanding the foregoing, Stockholder may make transfers of Shares (a) by will or by operation of law or other transfers for estate-planning purposes, in
which case this Agreement shall bind all transferees, and (b) as Parent may otherwise agree in writing in its sole discretion. Notwithstanding anything contained herein to the contrary, nothing in this Agreement shall prohibit or prevent the
cashless exercise of any Company Stock Options by Stockholder. 
 5. Representations and Warranties of Stockholder.
Stockholder hereby represents and warrants to Parent and the Company as follows: 
 (a) Stockholder has the full power and
authority to execute and deliver this Agreement and to perform Stockholder’s obligations hereunder; 
 (b) this Agreement
has been duly executed and delivered by or on behalf of Stockholder and, to Stockholder’s knowledge and assuming this Agreement constitutes a valid and binding agreement of Parent and the Company, constitutes a valid and binding agreement with
respect to Stockholder, enforceable against Stockholder in accordance with its terms, except as enforcement may be limited by general principles of equity whether applied in a court of law or a court of equity and by bankruptcy, insolvency and
similar laws affecting creditors’ rights and remedies generally; 
 (c) except as set forth on Schedule 1,
Stockholder beneficially owns the number of Shares indicated opposite Stockholder’s name on Schedule 1, and will own any New

  

 2 








 
Shares, free and clear of any liens, claims, security interests, pledges or other encumbrances or restrictions of any kind or nature whatsoever (“Liens”) except for any
restrictions under applicable securities laws, and has sole, and otherwise unrestricted, voting power with respect to such Shares or New Shares and none of the Shares or New Shares is subject to any voting trust or other agreement, arrangement or
restriction with respect to the voting of the Shares or the New Shares, except as contemplated by this Agreement; 
 (d) to the
knowledge of Stockholder, the execution and delivery of this Agreement by Stockholder does not, and the performance by Stockholder of his or her obligations hereunder and the compliance by Stockholder with any provisions hereof will not, violate or
conflict with, result in a material breach of or constitute a material default (or an event that with notice or lapse of time or both would become a material default) under, or give to others any rights of termination, amendment, acceleration or
cancellation of, or result in the creation of any Liens on any Shares or New Shares pursuant to, any agreement, instrument, note, bond, mortgage, contract, lease, license, permit or other obligation or any order, arbitration award, judgment or
decree to which Stockholder is a party or by which Stockholder is bound, or any law, statute, rule or regulation to which Stockholder is subject or, in the event that Stockholder is a corporation, partnership, trust or other entity, any bylaw or
other organizational document of Stockholder; and 
 (e) to the knowledge of Stockholder, the execution and delivery of this
Agreement by Stockholder does not, and the performance of this Agreement by Stockholder does not and will not, require any consent, approval, authorization or permit of, or filing with or notification to, any governmental or regulatory authority by
Stockholder except for applicable requirements, if any, of the Exchange Act, and except where the failure to obtain such consents, approvals, authorizations or permits, or to make such filings or notifications, would not prevent or delay the
performance by Stockholder of his or her obligations under this Agreement in any material respect. 
 6. Irrevocable
Proxy. Subject to the last sentence of this Section 6, by execution of this Agreement, Stockholder does hereby appoint Adrian N. Hobden, Ph.D., President and Chief Executive Officer of Parent, Robert J. Lollini, Chief Financial Officer of
Parent, and Andrew Gibbs, Secretary of Parent, and each of them, with full power of substitution and resubstitution, as Stockholder’s true and lawful attorney and proxy, to the fullest extent of the undersigned’s rights with respect to the
Shares, to vote, if Stockholder is unable to perform his or her obligations under this Agreement, each of the Shares and New Shares solely with respect to the matters set forth in Section 1 hereof. Stockholder intends this proxy to be
irrevocable and coupled with an interest hereunder until the Expiration Date in accordance with the provisions of Section 212 of the DGCL and hereby revokes any proxy previously granted by Stockholder with respect to the Shares and represents
that none of such previously granted proxies are irrevocable. Notwithstanding anything contained herein to the contrary, this irrevocable proxy shall automatically terminate upon the Expiration Date of this Agreement. 
 7. No Solicitation. From and after the date hereof until the Expiration Date, Stockholder, insofar as Stockholder is acting in his,
her or its capacity as a stockholder of the Company, shall not (a) initiate, solicit, seek or knowingly encourage or support any inquiries, proposals or offers that constitute or may reasonably be expected to lead to, a Company

  

 3 








 
Acquisition Proposal, (b) engage or participate in, or knowingly facilitate, any discussions or negotiations regarding, or furnish any nonpublic information to any Person in connection with,
any inquiries, proposals or offers that constitute, or may reasonably be expected to lead to, a Company Acquisition Proposal, (c) enter into any letter of intent, agreement in principle or other similar type of agreement relating to a Company
Acquisition Proposal, or enter into any agreement or agreement in principle requiring the Company to abandon, terminate or fail to consummate the transactions contemplated by the Merger Agreement, (d) initiate a stockholders’ vote or
action by consent of the Company’s stockholders with respect to a Company Acquisition Proposal, (e) except by reason of this Agreement, become a member of a “group” (within the meaning of Section 13(d) of the Exchange Act)
with respect to any voting securities of the Company that takes any action in support of a Company Acquisition Proposal or (f) propose or agree to do any of the foregoing. In the event that Stockholder is a corporation, partnership, trust or
other entity, it shall not permit any of its Subsidiaries or Affiliates to, nor shall it authorize any officer, director or representative of Stockholder, or any of its Subsidiaries or Affiliates to, undertake any of the actions contemplated by this
Section 7. Nothing in this Section 7 shall restrict any actions permitted under the Merger Agreement by Stockholder in his or her capacity as an officer or director of the Company. 
 8. Fiduciary Responsibilities. Stockholder makes no agreement or understanding herein in his or her capacity as a director or officer
of the Company. Without limiting the generality of the foregoing, Stockholder (or a designee of Stockholder) signs solely in his or her capacity as the record and beneficial owner of Stockholder’s Shares and nothing herein shall limit or affect
any actions taken by Stockholder (or a designee of Stockholder) in his or her capacity as an officer or director of the Company in exercising his or her or the Company’s or the Company’s Board of Directors’ rights in connection with
the Merger Agreement or otherwise and such actions shall not be deemed to be a breach of this Agreement. 
 9. Specific
Enforcement. The parties hereto agree that irreparable damage would occur in the event any provision of this Agreement was not performed in accordance with the terms hereof or was otherwise breached. It is accordingly agreed that the parties
shall be entitled to seek specific relief hereunder, including, without limitation, an injunction or injunctions to prevent and enjoin breaches of the provisions of this Agreement and to enforce specifically the terms and provisions hereof, in any
state or federal court in any competent jurisdiction, in addition to any other remedy to which they may be entitled at law or in equity. Any requirements for the securing or posting of any bond with respect to any such remedy are hereby waived.

 10. Further Assurances. Stockholder shall, from time to time, execute and deliver, or cause to be executed and
delivered, such additional or further consents, documents and other instruments as Parent or the Company may reasonably request for the purpose of effectively carrying out the transactions contemplated by this Agreement and the Merger Agreement.

 11. Disclosure. Stockholder hereby agrees that Parent and the Company may publish and disclose in the Registration
Statement (including all documents and schedules filed with the SEC), the Joint Proxy Statement, any Current Report on Form 8-K required to be filed in connection with the Merger, any filing with any regulatory authority in connection with the
Merger and any related documents filed with such regulatory authority and as otherwise required

  

 4 








 
by Law, Stockholder’s identity and ownership of Shares and New Shares and the nature of Stockholder’s commitments, arrangements and understandings under this Agreement and may further
file this Agreement as an exhibit to the Registration Statement or prospectus or in any other filing made by Parent or the Company as required by Law or the terms of the Merger Agreement, including with the SEC or other regulatory authority,
relating to the Merger, all subject to prior review and an opportunity to comment by Parent’s and the Company’s counsel. 
 12. Notice. All notices and other communications hereunder shall be in writing and shall be deemed given if delivered personally or sent by nationally-recognized overnight courier (providing proof of delivery) or by electronic mail
(providing a copy to be delivered by mail) or by facsimile transmission (providing confirmation of transmission) to Parent or the Company, as the case may be, in accordance with Section 12.02 of the Merger Agreement and to Stockholder at its
address set forth on Schedule 1 attached hereto (or at such other address for a party as shall be specified by like notice). 
 13. Severability. If any term or other provision of this Agreement is determined to be invalid, illegal or incapable of being enforced by any rule of law or public policy, all other conditions and provisions of this Agreement shall
nevertheless remain in full force and effect so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party. Upon such determination that any term or other provision
is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible to the fullest extent permitted by applicable law
in an acceptable manner to the end that the transactions contemplated hereby are fulfilled to the extent possible. 
 14.
Binding Effect and Assignment. All of the covenants and agreements contained in this Agreement shall be binding upon, and inure to the benefit of, the respective parties and their permitted successors, assigns, heirs, executors,
administrators and other legal representatives, as the case may be. Except as otherwise set forth in this Section 14, this Agreement may not be assigned by any party hereto without the prior written consent of the other parties hereto.

 15. No Third Party Beneficiaries. This Agreement is not intended, and shall not be deemed, to confer any rights or
remedies upon any person other than the parties hereto and their respective successors and permitted assigns, to create any agreement of employment with any person or to otherwise create any third-party beneficiary hereto. 
 16. No Waivers. No waivers of any breach of this Agreement extended by Parent or the Company to Stockholder shall be construed as a
waiver of any rights or remedies of Parent or the Company, as applicable, with respect to any other stockholder of the Company who has executed an agreement substantially in the form of this Agreement, with respect to Shares held or subsequently
held by such stockholder or with respect to any subsequent breach of Stockholder or any other such stockholder of the Company. No waiver of any provisions hereof by any party shall be deemed a waiver of any other provisions hereof by any such party,
nor shall any such waiver be deemed a continuing waiver of any provision hereof by such party. 
  

 5 








 17. Governing Law; Jurisdiction and Venue. THIS AGREEMENT IS MADE UNDER, AND SHALL BE
CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF DELAWARE, WITHOUT GIVING EFFECT TO PRINCIPLES OF CONFLICTS OF LAW. In any action between or among any of the parties, whether arising out of this Agreement or otherwise,
(a) each of the parties irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue of the state and federal courts located in New Castle County, Delaware; (b) if any such action is commended in a state
court, then, subject to applicable law, no party shall object to the removal of such action to any federal court located in New Castle County, Delaware; (c) each of the parties irrevocably waives the right to trial by jury; and (d) each of
the parties irrevocably consents to service of process by first class certified mail, return receipt requested, postage prepared, to the address at which such party is to receive notice in accordance with Section 12. 
 18. Waiver of Jury Trial. The parties hereto hereby waive any right to trial by jury with respect to any action or proceeding related
to or arising out of this Agreement, any document executed in connection herewith and the matters contemplated hereby and thereby. 
 19. No Agreement Until Executed. Irrespective of negotiations among the parties or the exchanging of drafts of this Agreement, this Agreement shall not constitute or be deemed to evidence a contract, agreement, arrangement or
understanding between the parties hereto unless and until (a) the Board of Directors of the Company has approved, for purposes of any applicable anti-takeover laws and regulations and any applicable provision of the Company’s Certificate
of Incorporation, the transactions contemplated by the Merger Agreement, (b) the Merger Agreement is executed by all parties thereto, and (c) this Agreement is executed by all parties hereto. 
 20. Entire Agreement; Amendment. This Agreement supersedes all prior agreements, written or oral, among the parties hereto with
respect to the subject matter hereof and contains the entire agreement among the parties with respect to the subject matter hereof. This Agreement may not be amended, supplemented or modified, and no provisions hereof may be modified or waived,
except by an instrument in writing signed by each party hereto. 
 21. Effect of Headings. The section headings herein
are for convenience only and shall not affect the construction or interpretation of this Agreement. 
 22. Counterparts.
This Agreement may be executed and delivered, including by facsimile transmission, in one or more counterparts, each of which will be deemed an original but all of which together shall constitute one and the same instrument. 
  

 6 








 EXECUTED as of the date first above written. 
  

			
	STOCKHOLDER
	
	  

	 Name:
	 	
	
	MYRIAD PHARMACEUTICALS, INC.
		
	 By:
	 	  

	 Name:
	 	Adrian N. Hobden
	 Title:
	 	President and Chief Executive Officer
	
	JAVELIN PHARMACEUTICALS, INC.
		
	 By:
	 	  

	 Name:
	 	Martin J. Driscoll
	 Title:
	 	Chief Executive Officer









 Schedule of Signatories 
  

	•	 	 Martin J. Driscoll 


  

	•	 	 Jackie M. Clegg 


  

	•	 	 Neil W. Flanzraich 


  

	•	 	 Peter D. Kiernan, III 


  

	•	 	 Fred H. Mermelstein 


  

	•	 	 Georg Nebgen 


  

	•	 	 Douglas G. Watson 


  

	•	 	 Stephen J. Tulipano 


  

	•	 	 Daniel B. Carr